Your browser doesn't support javascript.
loading
Bystander activation and autoimmunity.
Pacheco, Yovana; Acosta-Ampudia, Yeny; Monsalve, Diana M; Chang, Christopher; Gershwin, M Eric; Anaya, Juan-Manuel.
Affiliation
  • Pacheco Y; Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
  • Acosta-Ampudia Y; Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
  • Monsalve DM; Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
  • Chang C; Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis, School of Medicine, Davis, CA, USA; Pediatric Immunology and Allergy, Joe DiMaggio Children's Hospital, Hollywood, FL, USA.
  • Gershwin ME; Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis, School of Medicine, Davis, CA, USA. Electronic address: megershwin@ucdavis.edu.
  • Anaya JM; Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia; Clínica del Occidente, Bogotá, Colombia. Electronic address: juan.anaya@urosario.edu.co.
J Autoimmun ; 103: 102301, 2019 09.
Article in En | MEDLINE | ID: mdl-31326230
ABSTRACT
The interaction over time of genetic, epigenetic and environmental factors (i.e., autoimmune ecology) increases or decreases the liability an individual would have to develop an autoimmune disease (AD) depending on the misbalance between risk and protective effects. Pathogens have been the most common antecedent events studied, but multiple other environmental factors including xenobiotic chemicals, drugs, vaccines, and nutritional factors have been implicated into the development of ADs. Three main mechanisms have been offered to explain the development of autoimmunity molecular mimicry, epitope spreading, and bystander activation. The latter is characterized by auto-reactive B and T cells that undergo activation in an antigen-independent manner, influencing the development and course of autoimmunity. Activation occurs due to a combination of an inflammatory milieu, co-signaling ligands, and interactions with neighboring cells. In this review, we will discuss the studies performed seeking to define the role of bystander activation in systemic and organ-specific ADs. In all cases, we are cognizant of individual differences between hosts and the variable latency time for clinical expression of disease, all of which have made our understanding of the etiology of loss of immune tolerance difficult and enigmatic.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Autoimmune Diseases / T-Lymphocytes / Xenobiotics / Bystander Effect Type of study: Etiology_studies Limits: Animals / Humans Language: En Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Autoimmune Diseases / T-Lymphocytes / Xenobiotics / Bystander Effect Type of study: Etiology_studies Limits: Animals / Humans Language: En Year: 2019 Type: Article